Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese

Neuroscience Letters

Volumn 349, Issue 3, 2003, Pages 209-211

  Zhang, Peng ^a   Yang, Ze ^b   Zhang, Chuanfang ^a   Lu, Zeping ^c   Shi, Xiaohong ^b   Zheng, Weidong ^b   Wan, Chunling ^a   Zhang, Duanyang ^a   Zheng, Chenguang ^c   Li, Shu ^a   Jin, Feng ^a   Wang, Li ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b BEIJING HOSPITAL   (China)

^c Guangxi Zhuangzu Zizhiqu Jiangbin Yiyuan   (China)

Author keywords

Alzheimer's disease; Apolipoprotein E; Chinese; Gene polymorphisms; Transferrin

Indexed keywords

APOLIPOPROTEIN E; TRANSFERRIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK;

EID: 0142091430     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00837-1     Document Type: Article

References (12)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition:1994;American Psychiatric Association, Washington, DC.
2. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48:1997;139-147.
3. Hu X.F., Zhang X.R., Xuan A., Cao X.R. Association between Apolipoprotein E gene polymorphism and the patients with persistent vegetative state in the Chinese. Acta Genetica Sinica. 29:2002;757-760.
4. Kim K.W., Jhoo J.H., Lee J.H., Lee D.Y., Lee K.U., Youn J.Y., Woo J.I. Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans. Neurosci. Lett. 308:2001;45-48.
5. Loeffler D.A., Connor R., Juneau P.L., Snyder B.S., Kanaley L., DeMaggio A.J., Nguyen H., Brickman C.M., LeWitt P.A. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65:1995;710-724.
6. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
7. McKhamm G., Drachman D., Folstein M., Datzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
8. Namekata K., Imagawa M., Terashi A., Ohta S., Oyama F., Ihara Y. Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum. Genet. 101:1997;126-129.
9. Tanzi R.E. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J. Clin. Invest. 104:1999;1175-1179.
10. Van Landeghem G.F., Sikstrom C., Beckman L.E., Adolfsson R., Beckman L. Transferrin C2, metal binding and Alzheimer's disease. NeuroReport. 9:1998;177-179.
11. Van Rensburg S.J., Carstens M.E., Potocnik F.C., Aucamp A.K., Taljaard J.J. Increased frequency of the transferrin C2 subtype in Alzheimer's disease. NeuroReport. 4:1993;1269-1271.
12. Wong C.T., Saha N. Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta Haematol. 75:1986;215-218.